The US Food and Drug Administration (FDA) has approved Pfizer’s Daurismo (glasdegib) indication to treat patients with newly diagnosed acute myeloid leukaemia (AML). The once-daily oral medicine is the first and only FDA-approved Hedgehog pathway […]
Life sciences company Cambrex has agreed to acquire Avista Pharma Solutions, a North Carolina-based contract development, manufacturing, and testing organization, for about $252m. Through the acquisition of Avista, Cambrex will be adding early stage small […]
SMI REPORTS: SMi Group speak toJames Mellman, Device Manager, Novartis, Co-Chair of Pre-Filled Syringes 2019 SMi Group are delighted to haveJames Mellman, Device Manager, Novartis, Co-Chair the 11th annual conference and exhibition on Pre-Filled Syringes& […]
SMi Reports: This year’s RNA Therapeutics Conference Chair Ekkehard Leberer, Senior Director at Sanofi-Aventis Deutschland GmbH, has released a letter of invitation detailing next year’s event. SMi’s 10th annual RNA Therapeutics Conference is set to […]
SMi Reports: The World Health Organisationis set to speak and present at this year’s Superbugs &SuperdrugsConference, taking place in London, UK on 18th– 19th March 2019. As the worldwidedanger of antimicrobial resistance remainsa threat, the […]